Kiadis Pharma Stock (AMS:KDS)

NETHERLANDS |AS |EUR

Price
5.46
Change
0.18%
Today's Range
€5.37 - €5.45
52-Week Range
€5.25 - €5.47
Market Cap
€220.08M
Volume
10.59K

About Kiadis Pharma (AMS:KDS)

(AMS:KDS) Kiadis Pharma N.V., a biopharmaceutical company, develops cell-based immunotherapy products in the field of blood building system. The company develops K-NK002 as an adjunctive immunotherapeutic, which is in Phase II clinical trials for blood cancer patients undergoing a haploidentical HSCT with the post-transplant cyclophosphamide (PTCy) protocol; and K-NK003, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia relapse/refractory (AML R/R). The company's preclinical stage product include K-NK00X, a NK-cell therapy candidate for the treatment of various solid tumors. It has a collaboration agreement with Harbour BioMed, Utrecht University, Erasmus Medical Center, and Viroclinics-DDL for the development of a combination of a monoclonal antibody and natural killer cells as a treatment for COVID-19. Kiadis Pharma N.V. was founded in 1997 and is headquartered in Amsterdam, the Netherlands.
Show more

KDS Stock Price

Statistics Highlights (AMS:KDS)

Shares Outstanding 40.31M Beta 5.18
Public Float 29.81M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 97.39% Ex-Dividend Date
Held by Institutions 4.45% IPO Date -

KDS Financial Summary

|
Dec 20 Dec 19 Dec 18
Revenue €17.50M €0.00 €0.00
EBITDA €-77.50M €-46.00M €-24.44M
Net Income €-81.94M €-52.63M €-29.80M
Total Assets €62.76M €79.50M €82.54M
Total Cash €13.66M €29.46M €60.31M
Total Debt
Dec 20 Sep 20 Jun 20
Revenue
EBITDA
Net Income
Total Assets €62.76M €68.12M
Total Cash €13.66M €19.81M
Total Debt

KDS Stock Price History

Kiadis Pharma Annual Stock Price History

Year Open Close Change
2020 €1.99 €5.29 165.83%

(AMS:KDS) Stock Price FAQs

What is today's stock price of Kiadis Pharma (AMS:KDS)?

  • The current stock price of Kiadis Pharma (AMS:KDS) is €5.46.
  • Today KDS stock price opened at €5.37 after previous close of €5.45.
  • During the day, Kiadis Pharma stock quote has varied from a low of €5.37 to a high of €5.45.

What is Kiadis Pharma's 52-week change?

  • KDS 52-week high stock quote is €5.47, which is 0.20% above the current share price.
  • The Kiadis Pharma (AMS:KDS) 52-week low stock price is €5.25, which is 3.90% below the current share price.
  • Kiadis Pharma share price volatility (52-week beta) is 5.18.

Kiadis Pharma (AMS:KDS) FAQ

How Much is Kiadis pharma Worth?

Kiadis pharma's worth today based on market capitalisation is €220.08M

How much dividend does Kiadis pharma Pay?

The current annualized dividend payout for KDS stock is €0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Kiadis pharma's "Dividend" Section

What is Kiadis pharma’s Price to Earning (PE) ratio?

KDS stock also has a Price to Sales (P/S) ratio of 11.42.

What is the Kiadis pharma's ticker?

Kiadis pharma trades on the Euronext Amsterdam stock market in Netherlands under the ticker symbol "KDS". Kiadis pharma’s stock symbol can also be displayed as "AMS:KDS".

Who are the owners of Kiadis pharma?

Kiadis pharma (AMS:KDS) is owned by 4.45% institutional shareholders and by 97.39% insiders. The rest is owned by the public.
Explore More Details on Kiadis pharma's “Ownership” Section

Who are the key executives of Kiadis pharma (KDS)?

Kiadis pharma's key executive team includes the following managers:

  • Mr. Paul van Hagen, Sr. VP of Fin. (NA)
  • Mr. Dirk De Naeyer, Chief Operations Officer (NA)
  • Dr. Robert Friesen Ph.D., Chief Scientific Officer (NA)
  • Maryann Cimino, Sr. Mang. of Investor Relations & Corp. Affairs (NA)
  • Ms. Margot Hoppe, Gen. Counsel & Corp. Sec. (1964)
  • Dr. Andrew Seth Sandler M.D., Chief Medical Officer (1965)
  • Ms. Martine Nolan, Sr. VP of Quality (NA)
  • Dr. Govert J. Schouten Ph.D., Head of Innovation (NA)
  • Dr. Marion Zerlin, Head of CMC Global Project Management (NA)

What is Kiadis pharma’s Sector & Industry Classification?

Kiadis pharma (AMS:KDS) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Kiadis pharma?

Currently the number of employees working for Kiadis pharma is 103.

Where are Kiadis pharma's Headquarters?

Kiadis pharma (AMS:KDS) is headquartered in Netherlands.

What are Kiadis pharma's Address and Phone Number?

Kiadis pharma’s mailing address is Paasheuvelweg 25A, Amsterdam, Netherlands, 1105 BP.
The company’s phone number is 31 20 240 5250.

What is the official website for Kiadis pharma?

Kiadis pharma’s official website is http://www.kiadis.com